PRICE T ROWE ASSOCIATES INC /MD/ - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2021$117,000
-38.1%
54,0950.0%0.00%
Q2 2021$189,000
-96.7%
54,095
-90.7%
0.00%
-100.0%
Q1 2021$5,708,000
-68.2%
578,926
-65.1%
0.00%
-50.0%
Q4 2020$17,967,000
+65.3%
1,657,433
+57.1%
0.00%
+100.0%
Q3 2020$10,868,000
-75.5%
1,055,133
-50.3%
0.00%
-83.3%
Q2 2020$44,363,000
+85.1%
2,124,648
-13.4%
0.01%
+50.0%
Q1 2020$23,969,000
+66.2%
2,453,366
+96.0%
0.00%
+100.0%
Q4 2019$14,421,000
+153.0%
1,251,787
+19.7%
0.00%
+100.0%
Q3 2019$5,701,000
-14.1%
1,046,102
+87.5%
0.00%0.0%
Q2 2019$6,635,000558,0360.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 6,552,068$14,218,0008.03%
Versant Venture Management, LLC 5,068,233$10,998,0004.55%
K2 PRINCIPAL FUND, L.P. 1,653,874$3,589,0000.29%
RTW INVESTMENTS, LP 7,483,757$16,240,0000.24%
Avoro Capital Advisors LLC 6,950,000$15,082,0000.24%
Artal Group S.A. 3,000,000$6,510,0000.15%
ALGERT GLOBAL LLC 231,490$502,0000.07%
Virtus ETF Advisers LLC 57,768$125,0000.06%
Pinz Capital Management, LP 53,600$116,0000.05%
TWIN FOCUS CAPITAL PARTNERS, LLC 100,000$217,0000.05%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders